Health+Benefits

How Disruptive is Medicare for All?

It’s no secret that a government-controlled healthcare system would be disruptive—not only to the 156 million Americans with employer-sponsored healthcare, but also to those whom would be taxed to fund the system, which is how the proposed arrangements would operate sans copays or cost sharing.
By Katie King Posted on December 5, 2018

It’s no secret that a government-controlled healthcare system would be disruptive—not only to the 156 million Americans with employer-sponsored healthcare, but also to those whom would be taxed to fund the system, which is how the proposed arrangements would operate sans copays or cost sharing. What we know is that there are at least six Medicare expansion plans before Congress. Single-payer legislation establishes one government-administered health plan, while public option bills would allow a government option to be sold alongside private options. Check out our breakdown:

Note: We recognize that when the next Congress begins in January, other single-payer and public option proposals may be introduced.

Sources: Kane, Arielle. “Progressives and Health Care: What Comes Next?” Progressive Policy Institute, 24 Oct. 2018, www.progressivepolicy.org/publications/progressives-and-health-care-what-comes-next/.

For more details, see this memo created by our legal team at Steptoe & Johnson.

Want to know what individual states are doing? Click here to see single-payer and public option proposals at the state level.

Katie King Vice President, Health Policy & Strategy, The Council Read More

More in Health+Benefits

ICHRAs Might Actually Be the Future
Health+Benefits ICHRAs Might Actually Be the Future
The case for employers to offer individual coverage health reimbursement arrange...
Health+Benefits Same Treatments, Dramatically Different Costs
Q&A with Allison Oakes, Chief Research Officer, Trilliant Health
Choosing Vision Benefits Isn’t All About the Premium
Health+Benefits Choosing Vision Benefits Isn’t All About the Premium
Q&A with Jason Rome, Chief Commercial Officer, EyeMed
Sponsored By EyeMed